series-a
Stage
1
Investors
About
DynamoBio AG develops advanced biotechnology tools to create more accurate human biology models, improving the prediction of disease and treatment outcomes beyond traditional animal testing.
Explore DynamoBio AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.